Effect of Continuous Care Model on Self-management in patients with systemic lupus erythematosus

The Effect of Continuous Care Model on Self-Management In patients with Systemic Lupus Erythematosus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200810048354N1

Enrollment

Registered

2020-09-12

Start date

2019-10-23

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Lupus Erythematosus. Systemic lupus erythematosus (SLE)

Interventions

Intervention 1: Intervention group: Intervention group: before starting the research and intervention, Informed consent form would be completed by patients and they will be informed about research met

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: Adults Over 20 years Old Their disease diagnosed less than a year Ability to Read and Write Willing to participate in the study Ability to comprehend Persian Be able to make contact for the follow-up stage of the study Lack of motion Defect

Exclusion criteria

Exclusion criteria: Reluctance to continue research Incidence of debilitating complication during research

Design outcomes

Primary

Measure	Time frame
Self management score based on PIH questionnaire. Timepoint: Evaluating self management score before the intervention and during eight weeks of intervention. Method of measurement: Partners in Health questionnaire.	—

Secondary

Measure	Time frame
Knowledge score. Timepoint: Evaluating knowledge score before the intervention and during eight weeks of intervention. Method of measurement: Partners in Health questionnaire.;Recognition and management of symptoms score. Timepoint: Evaluating recognition and management of symptoms score before the intervention and during eight weeks of intervention. Method of measurement: Partners in Health questionnaire.;Coping score. Timepoint: Evaluating coping score before the intervention and during eight weeks of intervention. Method of measurement: Partners in Health questionnaire.;Partnership in treatment. Timepoint: Evaluating Partnership in treatment score before the intervention and during eight weeks of intervention. Method of measurement: Partners in Health questionnaire.	—

Measure

Time frame

Knowledge score. Timepoint: Evaluating knowledge score before the intervention and during eight weeks of intervention. Method of measurement: Partners in Health questionnaire.;Recognition and management of symptoms score. Timepoint: Evaluating recognition and management of symptoms score before the intervention and during eight weeks of intervention. Method of measurement: Partners in Health questionnaire.;Coping score. Timepoint: Evaluating coping score before the intervention and during eight weeks of intervention. Method of measurement: Partners in Health questionnaire.;Partnership in treatment. Timepoint: Evaluating Partnership in treatment score before the intervention and during eight weeks of intervention. Method of measurement: Partners in Health questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNegin Hosseini hamze

Tehran University of Medical Sciences

n-hosseinihamze@razi.tums.ac.ir+98 21 3306 6727

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026